IMMUNOFRONTIER INC.
ImmunoFrontier, Inc. a Japanese drug discovery venture company. ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects for the wide range of cancers, especially the hard-to-treat esophageal, prostate and lung cancers and for the treatment of intractable immune diseases.
IMMUNOFRONTIER INC.
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.immunofrontier.com
Total Employee:
11+
Status:
Active
Contact:
+81-(0)3-5777-0710
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
PharmaDesign
PharmaDesign is a genomic drug discovery venture company.
Proteomedix Frontiers
Proteomedix Frontiers is drug discovery and development company.
Current Employees Featured
Official Site Inspections
http://www.immunofrontier.com
- Host name: sv8156.xserver.jp
- IP address: 183.181.88.157
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "ImmunoFrontier Inc."
About us โ ImmunoFrontier
Oct 5, 2004 ImmunoFrontier was founded in 2004 as a bio-venture company originating from Mie University. Since then, we have focused on the development of therapeutic cancer โฆSee details»
ImmunoFrontier โ ImmunoFrontier
Based on this, ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects against the wide range of cancers, especially the hard-to-treat โฆSee details»
ImmunoFrontier Inc. - Crunchbase Company Profile & Funding
ImmunoFrontier Inc. is a Japanese drug discovery venture company. ImmunoFrontier, Inc. a Japanese drug discovery venture company. ImmunoFrontier, Inc. aims to develop innovative โฆSee details»
ImmunoFrontier โ ImmunoFrontier
21ไธ็ดใซๅ ฅใใ้ฉๆฐ็ใชใใๆฒป็ๆณใฎ้็บใไธ็็ใซ็ใใซใชใฃใฆใใพใใใใฎๆฝฎๆตใฎใฒใจใคใจใใฆใไบบไฝใซๅ ใ ๅใใฃใฆใใใๅ ็ซใใๅฉ็จใ ใๆไฝๅป่ฌใใใใฏใฏใใณใๆณจ็ฎใ้ใ โฆSee details»
IMMUNOFRONTIER,INC. Company Profile - Dun & Bradstreet
IMMUNOFRONTIER,INC. Company Profile | OSAKA, OSAKA, Japan | Competitors, Financials & Contacts - Dun & BradstreetSee details»
IMMUNOFRONTIER,INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMMUNOFRONTIER,INC. of TSU, MIE. Get the latest business insights from Dun & Bradstreet.See details»
ImmunoFrontier, Inc. - Drug pipelines, Patents, Clinical trials
Last update 02 May 2024. ImmunoFrontier, Inc. Holding Company |See details»
ImmunoFrontier - Overview, News & Similar companies - ZoomInfo
Who is ImmunoFrontier. We are dedicated to the accurate, objective, and transparent reporting of scientific and clinical information and hope to provide a free resource f or the general public, โฆSee details»
ImmunoFrontier, Inc. - Products, Competitors, Financials, โฆ
Feb 5, 2010 ImmunoFrontier, Inc. is a biotech venture focused on the development of innovative immunotherapy treatments for cancer and immune diseases. The company specializes in โฆSee details»
ImmunoFrontier Inc. - Contacts, Employees, Board Members
Organization. ImmunoFrontier Inc. Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. ImmunoFrontier โฆSee details»
ImmunoFrontier - Company Profile - Tracxn
Oct 23, 2024 ImmunoFrontier - Protein and DNA vaccines for the treatment of cancer.. Raised funding from 1 investor. ImmunoFrontier has 2949 competitors.See details»
Business Operation โ ImmunoFrontier
While ImmunoFrontier, Inc has several core technologies, โCHP technologyโ is expected to be put into practical use ealiest of all. Wide range of application is now in progress to CHP cancer โฆSee details»
ImmunoFrontier Inc. - Tech Stack, Apps, Patents & Trademarks
ImmunoFrontier Inc. is actively using 3 technologies for its website, according to BuiltWith. These include SPF , Xserver , and Xserver DNS . Website Tech Stack by BuiltWithSee details»
Cancer vaccine(ImmunoFrontier, Inc.) - Drug Targets, Indications ...
A phase I+II clinical trial of vaccination with MAGE-A4 protein complexed with cholesteryl pullulan melanoma antigen gene-A4 nanogel (CHP-MAGE-A4) is currently underway in patients with โฆSee details»
Introduction โ ImmunoFrontier
Based on this, ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects against the wide range of cancers, especially the hard-to-treat โฆSee details»
IMMUNOFRONTIER INC innovation strategy - GoodIP
IMMUNOFRONTIER INC has a total of 16 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and โฆSee details»
Dose-dependent effects of NY-ESO-1 protein vaccine complexed โฆ
CHP-NY-ESO-1 complex vaccine (Drug code: IMF-001) was provided by ImmunoFrontier, Inc. (Tokyo, Japan). All processes were performed following current Good Manufacturing Practices โฆSee details»
Research programme: cancer vaccines - ImmunoFrontier
ImmunoFrontier is developing DNA and protein based cancer vaccines, which will produce an immune response directed against a number of tumour antigens. Research programme: โฆSee details»
ImmunoFrontierโs bussiness goals โ ImmunoFrontier
Urban Ace Higashitenma-BLDG.,1-1-19, Higashitenma,Kita-ku,Osaka,530-0044,JapanSee details»
Drug Discovery for Multifunctional Cancer DNA Vaccines
Jan 1, 2019 We are developing novel, next generation vaccines based on DNA immunization with multifunctional genes. In this technology, DNA vaccine carrying multiple genes encoding โฆSee details»